Status:
COMPLETED
Kinesia HomeView - Home Diary Comparison
Lead Sponsor:
Great Lakes NeuroTechnologies Inc.
Conditions:
Parkinson's Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective is to compare the sensitivity and test-retest reliability of Kinesia HomeView to electronic and hand-written diaries for tracking medication state in the home. Demonstrating comparable o...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Parkinson's disease
- On a stable antiparkinsonian medication regimen that includes levodopa for at least 4 weeks
- Experiencing dyskinesia more than 25% of the waking day (score ≥ 2 on Unified Parkinson's Disease Rating Scale item 32)
- With dyskinesias at least moderately disabling (score ≥ 2 on Unified Parkinson's Disease Rating Scale item 33)
- Capable of accurately completing diaries
- Capable of accurately using Kinesia HomeView
Exclusion
- Significant medical or psychiatric illness
- Subjects not capable of following the required clinical instructions
- Serious medical conditions that would compromise safety
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT01920425
Start Date
July 1 2013
End Date
September 1 2015
Last Update
January 12 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Great Lakes NeuroTechnologies Inc
Valley View, Ohio, United States, 44125